Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 5101 - 5125 of 6046 in total
Sub Class LM ID Name ▲ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Gangliosides LMSP0601DI06
  • KDN GD1a 2(d18:1/26:0)
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262625 1867.044183 C88H158N2O39
Gangliosides LMSP0601DI08
  • KDN GD1a 2(d18:1/26:1(17Z))
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262627 1865.028533 C88H156N2O39
Gangliosides LMSP0601EC00
  • KDN(2-6)lactotetraosylceramide
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG3022
Gangliosides LMSP0601EC01
  • KDN(2-6)lactotetraosylceramide(d18:1/16:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262764 1476.818813 C69H124N2O31
Gangliosides LMSP0601EC02
  • KDN(2-6)lactotetraosylceramide(d18:1/18:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262765 1504.850113 C71H128N2O31
Gangliosides LMSP0601EC03
  • KDN(2-6)lactotetraosylceramide(d18:1/20:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262766 1532.881413 C73H132N2O31
Gangliosides LMSP0601EC04
  • KDN(2-6)lactotetraosylceramide(d18:1/22:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262767 1560.912713 C75H136N2O31
Gangliosides LMSP0601EC05
  • KDN(2-6)lactotetraosylceramide(d18:1/24:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262768 1588.944013 C77H140N2O31
Gangliosides LMSP0601EC07
  • KDN(2-6)lactotetraosylceramide(d18:1/24:1(15Z))
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262770 1586.928363 C77H138N2O31
Gangliosides LMSP0601EC06
  • KDN(2-6)lactotetraosylceramide(d18:1/26:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262769 1616.975313 C79H144N2O31
Gangliosides LMSP0601EC08
  • KDN(2-6)lactotetraosylceramide(d18:1/26:1(17Z))
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262771 1614.959663 C79H142N2O31
Gangliosides LMSP0601CC01
  • KDN)GD1a(d18:1/16:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262396 1767.914232 C80H141N3O39
Gangliosides LMSP0601CC02
  • KDN)GD1a(d18:1/18:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262397 1795.945532 C82H145N3O39
Gangliosides LMSP0601CC03
  • KDN)GD1a(d18:1/20:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262398 1823.976832 C84H149N3O39
Gangliosides LMSP0601CC04
  • KDN)GD1a(d18:1/22:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262399 1852.008132 C86H153N3O39
Gangliosides LMSP0601CC05
  • KDN)GD1a(d18:1/24:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262400 1880.039432 C88H157N3O39
Gangliosides LMSP0601CC07
  • KDN)GD1a(d18:1/24:1(15Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262402 1878.023782 C88H155N3O39
Gangliosides LMSP0601CC06
  • KDN)GD1a(d18:1/26:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262401 1908.070732 C90H161N3O39
Gangliosides LMSP0601CC08
  • KDN)GD1a(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262403 1906.055082 C90H159N3O39
Gangliosides LMSP0601GG00
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG3023
Gangliosides LMSP0601GG01
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/16:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44263180 1476.818813 C69H124N2O31
Gangliosides LMSP0601GG02
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/18:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44263181 1504.850113 C71H128N2O31
Gangliosides LMSP0601GG03
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/20:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263182 1532.881413 C73H132N2O31
Gangliosides LMSP0601GG04
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/22:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263183 1560.912713 C75H136N2O31
Gangliosides LMSP0601GG05
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/24:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263184 1588.944013 C77H140N2O31

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024